CHCM
GSK icon

Columbus Hill Capital Management’s GSK GSK Stock Holding History

Columbus Hill Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-91,847
Closed -$4.95M – 62
2017
Q2 		$4.95M Sell
91,847
-2,553
-3% -$136K 0.5% 42
2017
Q1 		$4.97M Buy
+94,400
New +$4.79M 0.25% 47

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Columbus Hill Capital Management's GSK Position: Q3 2017 in Review

Columbus Hill Capital Management sold out of GSK (GSK) in Q3 2017, closing a stake of 91,847 shares — an estimated $4.95M sold.

Columbus Hill Capital Management first reported a position in GSK in Q1 2017 and held it in 2 quarters. The position peaked at $4.97M in Q1 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Columbus Hill Capital Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Columbus Hill Capital Management sold 91,847 GSK shares in Q3 2017, an estimated $4.95M.
  • Columbus Hill Capital Management first reported a position in GSK in Q1 2017 and held it in 2 quarters.
  • Columbus Hill Capital Management's GSK position peaked at $4.97M in Q1 2017.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Columbus Hill Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.